Second malignant neoplasms following childhood cancer: A study of a recent Cohort (19872004) from the childhood cancer registry of the Rhõne-Alpes Region (ARCERRA) in France

Pediatric Hematology and Oncology

Volumn 28, Issue 5, 2011, Pages 364-379

  Berger, Claire ^a,b   Trombert Paviot, Béatrice ^b,c   Casagranda, Léonie ^a,b   Mialou, Valérie ^d   Frappaz, Didier ^d,e   Plantaz, Dominique ^f   Collardeau Frachon, Sophie ^g   Freycon, Fernand ^b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d Institute of Pediatric Hematology and Oncology   (France)

^e CENTRE LÉON BÉRARD   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ LYON 1   (France)

Author keywords

bone marrow transplant; childhood; registry; second cancer; total body irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; EPIPODOPHYLLOTOXIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BASAL CELL CARCINOMA; BONE CANCER; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; DRUG MEGADOSE; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; FRANCE; GENETIC PREDISPOSITION; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG ALVEOLUS CELL CARCINOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; MUCOEPIDERMOID TUMOR; MYELODYSPLASTIC SYNDROME; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROFIBROMATOSIS; OVERALL SURVIVAL; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETINOBLASTOMA; SCHOOL CHILD; SECOND CANCER; SOFT TISSUE SARCOMA; SOLID TUMOR; STANDARDIZED INCIDENCE RATIO; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUBEROUS SCLEROSIS; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TIME FACTORS;

EID: 79960132471     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.562601     Document Type: Article

References (40)

1. de Vathaire F, Schweisguth O, Rodary C, et al. Long-termrisk of secondmalignant neoplasm after a cancer in childhood. Br J Cancer. 1989;59:448-452. (Pubitemid 19100018)
2. deVathaire F, Hawkins M, Campbell S, et al. Secondmalignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999;79:1884-1893. (Pubitemid 29132320)
3. Jenkinson HC, Hawkins MM, Stiller CA, et al. Long-termpopulation-based risks of secondmalignant neoplasms after childhood cancer in Britain. Br J Cancer. 2004;91:1905-1910. (Pubitemid 40065519)
4. Hammal DM, Bell CL, Craft AW, Parker L. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer. 2005;45:155-161. (Pubitemid 40993581)
5. Le Deley MC, Vassal G, Taïbi A, et al. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr Blood Cancer. 2005;45:25-31. (Pubitemid 40791742)
6. Guérin S, Hawkins M, Shamsaldin A, et al. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study. J Clin Oncol. 2007;25:2833-2839. (Pubitemid 47123193)
7. Cardous-Ubbink MC,Heinen RC, Bakker PJ, et al. Risk of secondmalignancies inlong-termsurvivors of childhood cancer. Eur J Cancer. 2007;43:351-362. (Pubitemid 46123988)
8. MacArthur AC, Spinelli JJ, Rogers PC, et al. Risk of a secondmalignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer. 2007;48:453-459. (Pubitemid 46340113)
9. Maule M, Scélo G, Pastore G, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst. 2007;99:790-800. (Pubitemid 47073525)
10. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207-1215. (Pubitemid 46465729)
11. Borgmann A, Zinn C, Hartmann R, et al. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer. 2008;44:257-268.
12. Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer. 2009;125:2400-2405.
13. Olsen JH, Möller T, Anderson H, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst. 2009;101:806-813.
14. Inskip PD, Curtis RE. Newmalignancies following childhood cancer in the United States, 1973-2002. Int J Cancer. 2007;121:2233-2240. (Pubitemid 47585603)
15. Vasudevan V, Cheung MC, Yang R, et al. Pediatric solid tumors and secondmalignancies: characteristics and survival outcomes. J Surg Res. 2010;160:184-189.
16. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629. (Pubitemid 32409629)
17. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings fromthe Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2356-2362.
18. Friedman DL,Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102:1083-1095.
19. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann InternMed. 2004;141:590-597. (Pubitemid 39390536)
20. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report fromthe Childhood Cancer Survivor Study. J Clin Oncol. 2005;23:3733-3741.
21. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report fromthe Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-483. (Pubitemid 46630467)
22. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: a report fromthe Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007;99:300-308. (Pubitemid 47073493)
23. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111:5515-5523.
24. Landgren O,Gilbert ES, Rizzo JD, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113:4992-5001.
25. Fritz A, Jack A, Percy C, et al.et al, eds. International Classification of Diseases for Oncology, Third Edition. Geneva, Switzerland:World Health Organization; 2000.
26. Steliarova-Foucher E, Stiller C, Lacour B,Kaatsch P. International Classification ofChildhood Cancer, Third Edition. Cancer. 2005;103:1457-1467. (Pubitemid 40410743)
27. Li FD, Fraumeni JF Jr. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969;43:1365-1373.
28. Belot A, Grosclaude P, Bossard N, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008;56:159-175.
29. Berger C, Trombert-Paviot B, Mitton N, et al. [Childhood cancer incidence and survival rates in the Rhõne-Alpes regional paediatric registry 1987-1999] [in French]. Arch Pediatr. 2006;13:121-129. (Pubitemid 43187906)
30. Desandes E, Lacour B, Belot A, et al. [Cancer incidence and survival among adolescents and young adults in France (1978-1997)] [in French]. Bull Cancer. 2007;94:331-337. (Pubitemid 46814047)
31. Breslow NE, Day NE, eds. StatisticalMethods in Cancer Research. Volume II: TheDesign and Analysis of Cohort Studies. IARC Scientific Publication No. 82. Lyon: IARC; 1987.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
33. Rihani R, Bazzeh F, Faqih N, Sultan I. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases fromthe Surveillance, Epidemiology, and EndResult-9 registry. Cancer. 2010;116:4385-4394.
34. Constine LS, Tarbell N, Hudson MM, et al. Subsequent malignancies in children treated for Hodgkins disease: associations with gender and radiation dose. Int J Radiat Oncol Biol Phys. 2008;72:24-33.
35. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkins disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386-4394. (Pubitemid 46621816)
36. Taylor AJ, Frobisher C, Ellison DW, et al. Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:5781-5787.
37. Cohen A, Rovelli A, Merlo DF, et al. Risk for secondary thyroid carcinoma after hematopoietic stemcell transplantation: an EBMT Late EffectsWorking Party Study. J Clin Oncol. 2007;25:2449-2454. (Pubitemid 46999216)
38. MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol. 2009;93:1159-1162.
39. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23:2272-2279. (Pubitemid 46218720)
40. Rizzo JD, Curtis RE, Socié G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009;113:1175-1183.